PROTAC
PROTAC(蛋白降解靶向嵌合体)
PROTACs or Proteolysis Targeting Chimeric Molecules are heterobifunctional nanomolecules that theoretically target any protein for ubiquitination and degradation. In terms of the structure, PROTACs consist of one moiety which is recognized by the E3 ligase. This moiety is then chemically and covalently linked to a small molecule or a protein that recognizes the target protein. The trimeric complex formation leads to the transfer of ubiquitins to the target protein.
By removing target proteins directly rather than merely blocking them, PROTACs can provide multiple advantages over small molecule inhibitors, which can require high systemic exposure to achieve sufficient inhibition, often resulting in toxic side effects and eventual drug resistance. PROTAC molecules possess good tissue distribution and the ability to target intracellular proteins, thus can be directly applied to cells or injected into animals without the use of vectors.
Targeted protein degradation using the PROTAC technology is emerging as a novel therapeutic method to address diseases, such as cancer, driven by the aberrant expression of a disease-causing protein. In addition to the use of PROTACs for the treatment of human disease, these molecules provide a chemical genetic approach to “knock down” proteins to study their function. Currently, there are several small molecule inhibitors that have been found to show good biological activity by specifically targeting BET, estrogen receptor (ER), androgen receptor, etc.
References:
[1] Sakamoto KM. Pediatr Res. 2010 May;67(5):505-8.
[2] Neklesa TK, et al. Pharmacol Ther. 2017 Jun;174:138-144.
- E3 Ligase Ligand-Linker Conjugate(181)
- Ligand for E3 Ligase(91)
- Ligand for Target Protein for PROTAC(37)
- PROTAC(148)
- PROTAC Linker(1696)
- SNIPER(9)
- Target Protein Ligand-Linker Conjugate(3)
- AUTAC(1)
- PROTAC and Building Blocks(17)
- Molecular Glues(16)
- Target Protein Ligand-Linker Conjugates(1)
- LYTACs(3)
- AUTOTACs(3)
PROTAC 相关产品(250)
- GC50658Pomalidomide 4'-alkylC3-amineCAS: 2154342-45-5纯度: >95.00%
Pomalidomide 4'-alkylC3-amine 是一种合成的 E3 连接酶配体-接头偶联物,它包含基于 Pomalidomide 的 cereblon 配体和 PROTAC 技术中使用的接头。
- GC50665Pomalidomide 4'-alkylC3-acidCAS: 2225940-47-4纯度: >95.00%
Functionalized cereblon ligand for research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal acid ready for conjugation to a target protein ligand
- GC50669Lenalidomide 4'-PEG1-amineCAS: 2624336-86-1纯度: >95.00%
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal amine ready for conjugation to a target protein ligand
- GC50674Pomalidomide 4'-alkylC4-acidCAS: 2225940-48-5纯度: >95.00%
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal acid ready for conjugation to a target protein ligand
- GC50675Pomalidomide 4'-PEG1-acidCAS: 2139348-60-8纯度: >99.50%
Pomalidomide 4'-PEG1-acid 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 cereblon 配体和 1 单位 PEG 接头。
- GC50684Lenalidomide 4'-PEG2-amineCAS: 2624336-88-3纯度: >95.00%
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal amine ready for conjugation to a target protein ligand
- GC50689Pomalidomide 4'-alkylC6-acidCAS: 2225940-50-9纯度: >95.00%
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal acid ready for conjugation to a target protein ligand
- GC50690Pomalidomide 4'-PEG2-acidCAS: 2140807-17-4纯度: >95.00%
Pomalidomide 4'-PEG2-acid (Pomalidomide 4'-PEG2-acid) 是一种合成的 E3 连接酶配体-接头偶联物,它包含基于 Pomalidomide 的 cereblon 配体和用于 PROTAC 技术的 2 单元 PEG 接头。
- GC50694Lenalidomide 4'-PEG3-amineCAS: 2624336-87-2纯度: >95.00%
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG3 linker with terminal amine ready for conjugation to a target protein ligand
- GC50696Pomalidomide 4'-alkylC8-acidCAS: 2305936-70-1纯度: >95.00%
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand
- GC50698VH 032, amineCAS: 2137142-47-1纯度: >98.00%
Derivative of the von Hippel-Lindau (VHL) ligand, VH 032; commonly used as a precursor to a PROTAC® that hijacks VHL as the E3 ubiquitin ligase component
- GC50705Pomalidomide 4'-PEG4-acidCAS: 2138440-81-8纯度: >95.00%
Pomalidomide-PEG4-COOH 是一种 E3 连接酶配体-接头偶联物,包含基于 Pomalidomide 的 cereblon 配体和用于 PROTAC 技术的 4 单元 PEG 接头。
- GC50709Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amineCAS: 2564466-93-7纯度: >95.00%
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand
- GC50712VH 032 amide-alkylC2-acidCAS: 2172819-72-4纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC2 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50714VH 032 amide-alkylC3-amineCAS: 2564467-25-8纯度: >95.00%
Functionalized von-Hippel-Lindau (VHL) protein ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkyl C3 linker and terminal amine ready for conjugation to a target protein ligand
- GC50718VH 032 amide-alkylC3-acidCAS: 2172819-73-5纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for research and development; incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50720VH 032 amide-PEG1-acidCAS: 2172820-07-2纯度: >95.00%
Functionalized von-Hippel-Lindau (VHL) protein ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50723VH 101 phenol-alkylC4-amineCAS: 2564467-03-2纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal amine ready for conjugation to a target protein ligand
- GC50724VH 032 amide-alkylC6-acidCAS: 2172819-75-7纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC6 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50729VH 101 phenol-alkylC6-amineCAS: 2564467-16-7纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal amine ready for conjugation to a target protein ligand
- GC50730VH 032 amide-alkylC8-acidCAS: 2172819-77-9纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC8 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
- GC50731VH 032 amide-PEG4-amineCAS: 2446474-04-8纯度: >95.00%
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand
- GC50737A 410099.1 amide-PEG4-amineCAS: 2446474-10-6纯度: >95.00%
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG4 linker with terminal amine ready for conjugation to a target protein ligand
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC50658 | Pomalidomide 4'-alkylC3-amine | 2154342-45-5 | >95.00% | |
Pomalidomide 4'-alkylC3-amine 是一种合成的 E3 连接酶配体-接头偶联物,它包含基于 Pomalidomide 的 cereblon 配体和 PROTAC 技术中使用的接头。 | ||||
| GC50665 | Pomalidomide 4'-alkylC3-acid | 2225940-47-4 | >95.00% | |
Functionalized cereblon ligand for research and development; incorporates an E3 ligase ligand plus an alkylC3 linker with terminal acid ready for conjugation to a target protein ligand | ||||
| GC50669 | Lenalidomide 4'-PEG1-amine | 2624336-86-1 | >95.00% | |
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50674 | Pomalidomide 4'-alkylC4-acid | 2225940-48-5 | >95.00% | |
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal acid ready for conjugation to a target protein ligand | ||||
| GC50675 | Pomalidomide 4'-PEG1-acid | 2139348-60-8 | >99.50% | |
Pomalidomide 4'-PEG1-acid 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 cereblon 配体和 1 单位 PEG 接头。 | ||||
| GC50684 | Lenalidomide 4'-PEG2-amine | 2624336-88-3 | >95.00% | |
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG2 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50689 | Pomalidomide 4'-alkylC6-acid | 2225940-50-9 | >95.00% | |
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal acid ready for conjugation to a target protein ligand | ||||
| GC50690 | Pomalidomide 4'-PEG2-acid | 2140807-17-4 | >95.00% | |
Pomalidomide 4'-PEG2-acid (Pomalidomide 4'-PEG2-acid) 是一种合成的 E3 连接酶配体-接头偶联物,它包含基于 Pomalidomide 的 cereblon 配体和用于 PROTAC 技术的 2 单元 PEG 接头。 | ||||
| GC50694 | Lenalidomide 4'-PEG3-amine | 2624336-87-2 | >95.00% | |
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG3 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50696 | Pomalidomide 4'-alkylC8-acid | 2305936-70-1 | >95.00% | |
Functionalized cereblon ligand for PROTAC(R) research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand | ||||
| GC50698 | VH 032, amine | 2137142-47-1 | >98.00% | |
Derivative of the von Hippel-Lindau (VHL) ligand, VH 032; commonly used as a precursor to a PROTAC® that hijacks VHL as the E3 ubiquitin ligase component | ||||
| GC50705 | Pomalidomide 4'-PEG4-acid | 2138440-81-8 | >95.00% | |
Pomalidomide-PEG4-COOH 是一种 E3 连接酶配体-接头偶联物,包含基于 Pomalidomide 的 cereblon 配体和用于 PROTAC 技术的 4 单元 PEG 接头。 | ||||
| GC50709 | Thalidomide 4'-oxyacetamide-alkylC1-PEG3-alkylC3-amine | 2564466-93-7 | >95.00% | |
Functionalized cereblon ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC1-PEG3-alkylC3 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50712 | VH 032 amide-alkylC2-acid | 2172819-72-4 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC2 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50714 | VH 032 amide-alkylC3-amine | 2564467-25-8 | >95.00% | |
Functionalized von-Hippel-Lindau (VHL) protein ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkyl C3 linker and terminal amine ready for conjugation to a target protein ligand | ||||
| GC50718 | VH 032 amide-alkylC3-acid | 2172819-73-5 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for research and development; incorporates an E3 ligase ligand plus alkylC3 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50720 | VH 032 amide-PEG1-acid | 2172820-07-2 | >95.00% | |
Functionalized von-Hippel-Lindau (VHL) protein ligand for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG1 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50723 | VH 101 phenol-alkylC4-amine | 2564467-03-2 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC4 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50724 | VH 032 amide-alkylC6-acid | 2172819-75-7 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC6 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50729 | VH 101 phenol-alkylC6-amine | 2564467-16-7 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus an alkylC6 linker with terminal amine ready for conjugation to a target protein ligand | ||||
| GC50730 | VH 032 amide-alkylC8-acid | 2172819-77-9 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus alkylC8 linker with terminal carboxylic acid ready for conjugation to a target protein ligand | ||||
| GC50731 | VH 032 amide-PEG4-amine | 2446474-04-8 | >95.00% | |
Functionalized von-Hippel-Lindau protein ligand (VHL) for PROTAC® research and development; incorporates an E3 ligase ligand plus a PEG linker ready for conjugation to a target protein ligand | ||||
| GC50736 | dBRD9-A | 2170679-42-0 | >98.00% | |
Potent BRD9 degrader | ||||
| GC50737 | A 410099.1 amide-PEG4-amine | 2446474-10-6 | >95.00% | |
Functionalized IAP ligand for PROTAC® research and development; incorporates an IAP ligand plus an amide-PEG4 linker with terminal amine ready for conjugation to a target protein ligand | ||||
